Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software.
about
Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic reviewDopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imagingNeurochemical changes within human early blind occipital cortex.Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartateEarly Alzheimer's disease neuropathology detected by proton MR spectroscopy.Brain changes in long-term zen meditators using proton magnetic resonance spectroscopy and diffusion tensor imaging: a controlled study.Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.Cortical and subcortical glutathione levels in adults with autism spectrum disorder.The evolving role of neurological imaging in neuro-oncology.Longitudinal magnetic resonance spectroscopy as marker of cognitive deterioration in mild cognitive impairment.Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study.Clinical and Radiological Differences in Alzheimer's Disease with and without a History of Mild Cognitive Impairment.
P2860
Q24630487-026E7451-B65D-41B3-8339-BF931E35BB03Q28538468-EEB50DFC-CC15-4993-B60B-AE0073391DDBQ30408825-73BA3E04-42A6-48E6-8D6A-B86F268BD23FQ34152954-2EB36D9B-61ED-4AE7-84CC-9B2955FA9D43Q34614543-1627ED97-8DBD-4428-A890-F5217512044DQ34639225-E4AF7889-4CE6-49A5-B6A5-12CC187F7A70Q35319467-8169A99C-21A4-438A-BBAE-5B4D26FA5BBDQ36600411-96EFDABC-71C8-492C-81EE-C42FB60689A8Q38235857-019BD188-9D56-44AD-93A0-958E830673D4Q48665796-341C442D-ECF5-4FA5-8551-4F0EC894ADDEQ48896363-98C74300-CA5C-4CAB-A0F2-DF31FD7E9EE4Q48955678-0FA9E458-366B-444F-94EA-5DB228CDAD59
P2860
Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comparative test-retest reliab ...... sus the manufacturer software.
@en
Comparative test-retest reliab ...... sus the manufacturer software.
@nl
type
label
Comparative test-retest reliab ...... sus the manufacturer software.
@en
Comparative test-retest reliab ...... sus the manufacturer software.
@nl
prefLabel
Comparative test-retest reliab ...... sus the manufacturer software.
@en
Comparative test-retest reliab ...... sus the manufacturer software.
@nl
P2093
P2860
P356
P1476
Comparative test-retest reliab ...... sus the manufacturer software.
@en
P2093
Jaime Medrano
Nicolas Fayed
Pedro J Modrego
P2860
P304
P356
10.1179/174313209X395481
P577
2009-02-12T00:00:00Z